← Back to Insights
October 28, 2020
David W. Johnson John Kerins
Innovation System Dynamics
4sight Radio & TV Interviews Podcasts

Cain Brothers House Calls Podcast: The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast

The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast

The race to develop a COVID-19 vaccine has put the clinical trial process under the microscope. Cain Brothers Managing Director, John Kerins, talks with Dave Johnson about innovations in clinical trials that reduce the barriers to participation, improve the diversity of patient populations, and accelerate the development of safe and effective vaccines. Cain Brothers is a division of KeyBanc Capital Markets.

Listen to this episode on Apple Podcasts, Spotify, and Google Podcasts.  

Read the related commentary here.

About the Authors

David W. Johnson

David Johnson is the CEO of 4sight Health, an advisory company working at the intersection of healthcare strategy, economics, innovation. Johnson is a healthcare thought leader, keynote speaker, and strategic advisor to organizations busting the status-quo to reform our healthcare system. He is the author of Market vs. Medicine: America’s Epic Fight for Better, Affordable Healthcare, and his second book, The Customer Revolution in Healthcare: Delivering Kinder, Smarter, Affordable Care for All (McGraw-Hill 2019). As a speaker, Dave plays the role of rebel, challenger, industry historian, investor and company evaluator to push audiences forward. (Watch bio video.) Johnson applies his 25+ years of investment banking in healthcare to identify ways the healthcare industry must change to deliver better care. He received a Masters in Public Policy from Harvard Kennedy School, an English degree from Colgate University, and served in the African Peace Corp service. Join over 10k+ healthcare executives who read our weekly insights and commentary on www.4sighthealth.com. His third book, Less Healthcare, More Health: The Prescription for a Happier, More Equitable and Productive America, will publish in 2024.

John Kerins

John Kerins is a Director in Cain Brother’s Corporate M&A Advisory practice. Mr. Kerins joined Cain Brothers in 2015 with 10+ years of experience in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Kerins’ notable transactions since joining Cain Brothers include the minority recapitalization of RedCard by Parthenon Capital Partners, the sale of iCardiac Technologies to ERT, the recapitalization of Steward Health Care System with Medical Properties Trust, the sale of Onlife to Guidewell, Morgan Stanley Capital Partners’ acquisition of Clarity, advising Premier Healthcare Exchange and Pay-Plus Solutions on their merger with Stratose, and BioScrip’s PIPE offering to Coliseum Capital Management. Prior to joining Cain Brothers, Mr. Kerins was a Vice President at Deloitte Corporate Finance LLC, where he focused on mergers, acquisitions, and fairness opinions across a variety of sectors. Mr. Kerins’ prior experience also includes working for McMaster-Carr Supply Company, a privately held distributor, in a variety of management capacities, including operations and sales management. Mr. Kerins earned a BA in Political Science from Kenyon College and an MBA from Fordham University.

Recent Posts

Podcast: What’s Ahead for CMS’ New AHEAD Demo? 9/14/23
How will CMS’ all-payer, global-budget demonstration project impact the push for more healthcare value and innovation? We talked… Read More
By September 14, 2023
How Healthcare Revolutionaries Think: 10 Questions With Marcus Whitney
Welcome to the latest installment of 4sight Health’s series, How Healthcare Revolutionaries Think. Our interview series profiles healthcare… Read More
By September 12, 2023
Default Image
System Dynamics
4sight Friday | Diagnostic Determinism Is Here | The Price of Physician-Hospital Vertical Integration | When Three Vendors Dominate the EHR Market
Read the 9/8/2023 Edition here. Subscribe here for weekly access. Curated by David Burda, 4sight Health’s news editor… Read More
By September 8, 2023